Since 2015, the World Anti-Microbial Resistance Congress has been the only commercially focused conference globally of its kind.
Launched during the release of key reports such as the AMR Review and A Scientific Roadmap for Antibiotic Discovery, the World AMR Congress has brought attention to the threats of this emerging crisis to the global healthcare system.
The conference gathers global leaders in infectious diseases to meet, brainstorm and discuss the challenges and opportunities on seven topic areas:
Antibiotic R&D: advancing the development of antibiotic and non-traditional therapies and improving commercialization strategies
Diagnostics: innovating the development and deployment of rapid diagnostics tests, while ensuring an effective integration into hospitals’ workflow and reimbursement
Antimicrobial stewardship: using technology to improve antibiotic prescription, monitoring and surveillance while advancing stewardship-based purchasing guidelines
Pitch & Partner: joining funding and partnerships with antibiotics and diagnostics innovation
Infection Control: advancing policies to improve infection prevention, control and compliance in healthcare facilities
Manufacturing: overcoming challenges for a sustainable and controlled antibiotic manufacturing and supply chain
Vaccines: discussing the clinical and economic value of vaccines to combat AMR
This November 7-8, 2019, 600 attendees from over 40 countries will be gathered at the Renaissance Washington, D.C. Downtown Hotel for the largest AMR conference ever.
We look forward to meeting you in D.C.